
Osheru
Ziplyft the first Minimally Invasive Surgery for Lids.
Date | Investors | Amount | Round |
---|---|---|---|
* | $4.7m | Seed | |
Total Funding | 000k |
Related Content
Ziplyft is a pioneering company in the field of minimally invasive eyelid surgery. The company has developed a patented FDA Class 1 device designed to simplify and enhance the process of eyelid surgery, making it more accessible for both surgeons and patients. The device features a clear design that allows surgeons to see the skin markings of the tissue to be removed, ensuring precise and symmetric placement. Its serrated jaws compress the skin to seal it, preventing bleeding and bruising, while a guarded blade cuts and removes the excess skin. The procedure eliminates the need for suturing by using a zipper lock closure that allows glue application, making the process less invasive and more efficient.
Ziplyft primarily serves eye and eyelid surgeons looking to offer a less invasive option for their patients. The market it operates in includes both the medical device sector and the cosmetic surgery industry. The business model revolves around the sale of its patented devices to medical professionals and clinics. Revenue is generated through the direct sale of these devices and potentially through training programs for surgeons.
The company's mission is to revolutionize eyelid surgery, making it easier on both the patient and the surgeon, and to expand the market of surgeons offering lid surgery as well as the market of patients desiring access to this vision and appearance-enhancing procedure.
Keywords: minimally invasive, eyelid surgery, FDA Class 1, patented device, cosmetic surgery, medical device, excess skin removal, vision enhancement, surgeon-friendly, non-suturing.